Precipio, Inc. — Director's Dealing 2008

May 22, 2008

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: TRANSGENOMIC INC (TBIO)
CIK: 0001043961
Period of Report: 2008-05-21

Reporting Person: Kaldjian Eric P (Chief Scientific Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
No Securities Owned	0	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Purchase Option	$.53	2017-12-30	Common Stock (33334)		Direct
Purchase Option	$.53	2017-12-30	Common Stock (33333)		Direct
Purchase Option	$.53	2017-12-30	Common Stock (33333)		Direct

Footnotes

F1: Common Stock, par value $.01 per share of Transgenomic, Inc.